Imuran Patient, Information, Instructions - Azathioprine

Imuran Patient, Information, Instructions - Azathioprine

PATIENT INFORMATION

Patients being started on azathioprine should be informed of the necessity of periodic blood counts while they are receiving the drug and should be encouraged to report any unusual bleeding or bruising to their physician. They should be informed of the danger of infection while receiving azathioprine and encouraged to report signs and symptoms of infection to their physician. Careful dosage instructions should be given to the patient, especially when azathioprine is being administered in the presence of impaired renal function or concomitantly with allopurinol (see DOSAGE AND ADMINISTRATION and DRUG INTERACTIONS). Patients should be advised of the potential risks of the use of azathioprine during pregnancy and during the nursing period. The increased risk of neoplasia following azathioprine therapy should be explained to the patient.

Laboratory Tests See WARNINGS and ADVERSE REACTIONS.